Introduction: Psychedelic-assisted therapy has resurfaced as a promising intervention for treatment-resistant psychiatric disorders. However, regulatory pathways differ considerably across countries because of social, ethical, legal, and political factors. Methods: This review was conducted using the regulatory frameworks of Australia, Brazil, and the USA, along with publicly accessible data,...